ATHX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 jan 2024 @ 21:58):

Stats
Dagens volum	6.46M
Gjennomsnittsvolum	1.77M
Markedsverdi	833 204
EPS	$0 ( 2024-03-29 )
Neste inntjeningsdato	( $0 ) 2024-05-16
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.00818
ATR14	$0.00600 (26.55%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-18	Hansen Maia	Sell	67	Common Stock
2023-10-04	Hansen Maia	Sell	23 149	Common Stock
2023-10-04	Camardo Daniel A.	Sell	19 993	Common Stock
2023-09-18	Hansen Maia	Sell	67	Common Stock
2023-08-17	Mayhugh Neema	Buy	27 428	NonQualified Stock Option (right to purchase)

INSIDER POWER
23.33
Last 94 transactions
Buy: 8 476 520 \| Sell: 1 272 175

Volum Korrelasjon

Lang: -0.02 (neutral)

Kort: 0.37 (neutral)

Signal:(49.051) Neutral

Athersys Inc Korrelasjon

10 Mest positive korrelasjoner
ADN	0.951
INVZ	0.95
ARVL	0.946
ATNF	0.946
KZR	0.944
CAAS	0.943
MPAA	0.94
BPYPN	0.939
PETS	0.939
MMAT	0.939

10 Mest negative korrelasjoner
NVCN	-0.951
STAY	-0.929
TIOA	-0.926
AVEO	-0.924
VCXA	-0.921
XM	-0.92
PCRX	-0.919
BRIVU	-0.919
ITMR	-0.915
ENER	-0.914

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Athersys Inc Korrelasjon - Valuta/Råvare

0.85
( strong )

0.79
( moderate )

0.00
( neutral )

0.78
( moderate )

-0.40
( neutral )

-0.67
( moderate negative )

Athersys Inc Økonomi

Annual	2022
Omsetning:	$5.33M
Bruttogevinst:	$5.33M (100.00 %)
EPS:	$-5.70

FY	2022
Omsetning:	$5.33M
Bruttogevinst:	$5.33M (100.00 %)
EPS:	$-5.70

FY	2021
Omsetning:	$5 514.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$0

FY	2020
Omsetning:	$1.44M
Bruttogevinst:	$1.44M (100.00 %)
EPS:	$-0.420

Financial Reports:

No articles found.

Athersys Inc

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.